Surotomycin-impurities | Pharmaffiliates


Surotomycin was an investigational oral antibiotic. This antibiotic was under investigation by Merck & Co (who acquired Cubist Pharmaceuticals) for the treatment of life-threatening Diarrhea, commonly caused by the bacterium Clostridium difficile. Reference standards of Surotomycin API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

PA 19 1630000

Surotomycin- API

  • Catalogue No.:PA 19 1630000

  • CAS :


  • Molecular Formula : C77H101N17O26

  • Molecular Weight : 1680.75